Novo Nordisk Failed to Warn Patients of the Risk of NAION and Permanent Blindness
After a thorough investigation into the link between Ozempic and Wegovy use and a unique form of vision loss, The Yost Legal Group has made the careful decision to take cases for individuals who were prescribed Ozempic or Wegovy and then suffered vision loss as a result of taking those medications.
At The Yost Legal Group, we believe people deserve full transparency about the medications they are prescribed by their doctors. Far too many individuals were never warned about a potentially blinding condition called non-arteritic anterior ischemic optic neuropathy (NAION).
Patients were told about the benefits of blood sugar control or weight loss, but not about the devastating impact on their eyesight. It is not their fault. They trusted their doctors and the billion-dollar corporation that manufactured and marketed these drugs, which sold the promise of a healthier life. But users were misled.
If you or a loved one were prescribed Ozempic or Wegovy and experienced sudden vision loss or blindness, you might have NAION. Seek a diagnosis from a medical professional.
If you or a loved one has been diagnosed with NAION after using Ozempic or Wegovy, you deserve to know your rights. Call the trusted defective drug lawyers at The Yost Legal Group today for a free consultation: 1-800-967-8529.
Understanding the Risk: What Is NAION?
NAION stands for non-arteritic anterior ischemic optic neuropathy. That is a mouthful (we know), so let us put it into layman’s terms: the front part of the optic nerve in your eye loses its blood supply. When that happens, nerve fibers die, and vision goes dark. The condition works quickly, painlessly, and often in just one eye.
Recovery is often incomplete, and for many people, the vision they lose does not come back. Over time, without proper warning or monitoring, it can lead to permanent blindness.
This is not a mild “blur” side effect. This is a severe, life-altering event. Optic nerve blood flow is compromised, and once damage sets in, there is no guaranteed fix.
Why Are Semaglutides Like Ozempic and Wegovy Under Fire?
Ozempic and Wegovy both rely on the same active ingredient: semaglutide, a GLP-1 receptor agonist. These drugs revolutionized treatment for type 2 diabetes and obesity, but their popularity skyrocketed almost overnight once they were linked to weight loss.
However, not all side effects were positive, and more troubling signs emerged as more people used them for more extended periods.
Scientists in a JAMA Ophthalmology study published in February 2025 reviewed data from over 16,000 patients with type 2 diabetes and found that those on semaglutide had a 32% higher risk of developing NAION compared to those who were not taking the drug.
Semaglutides are also known to change blood sugar levels dramatically, which makes sense as they are diabetes medications. These swings, however, can shift the shape of the eyes’ lenses, which may contribute to blurred vision, retinal stress, or other complications.
For diabetic patients, rapidly dropping blood sugar can paradoxically worsen preexisting diabetic retinopathy. In some people, retinal damage from years of high blood sugar can worsen as glucose levels normalize.
These are not hypothetical risks. They are real, documented, and potentially devastating to vision.
How People Were Misled. And Why That Matters
When millions are prescribed a medication, there is a responsibility to clearly spell out risks. That did not always happen here.
· No Adequate Warning of Permanent Vision Loss: The current drug labels mention vision changes, but very few mention NAION. That is not a simple oversight. In our legally informed opinion, that is a legal and ethical failure.
· Big Pharma Profits vs. Patient Safety: Novo Nordisk, the maker of Ozempic and Wegovy, made billions selling these drugs. But how aggressively did they communicate the full range of risks? Based upon what we are seeing, the answer is “Not nearly enough.” Patients trusted their doctors. Doctors trusted the studies. And patients took the drugs home, never the wiser that, in very rare cases, they were signing on for a potential fight to keep their sight.
· Lawsuits Are Not About Blame. They Are About Accountability: We are not here to shame patients. We are not suing doctors, many of whom were misled themselves. This was never about “You should have known better.” This is about what a billion-dollar Big Pharma company knew about its drug and what it did not disclose to potential users. This is about what patients were never told. This is about the drug maker’s failure to warn its users about a devastating potential adverse side effect. Whether it is a failure to warn claim or a broader product liability case for a defective drug, people who lost their vision deserve their chance at justice.
Who Is at Risk for Developing NAION?
NAION is not random. There are risk factors that seem to make some people more vulnerable. Those at an increased risk are people with the following conditions:
Diabetes
High blood pressure
High cholesterol
Sleep apnea
Crowded optic nerve head
Are living with any of these conditions? Please consult a medical professional before starting semaglutide. If you are living with any of these conditions and have suffered vision loss after using Ozempic or Wegovy, seek medical attention immediately.
Has you or a loved one lost their vision after using Ozempic for weight loss or Wegovy? You may qualify to file an Ozempic lawsuit. Call the experienced product liability lawyers at The Yost Legal Group today at 1-800-967-8529.
Ophthalmologists and Neuro-Ophthalmologists Raise Concerns
Some doctors call the link between semaglutide and non-arthritic anterior ischemic optic neuropathy (NAION) “plausible but not yet proven,” which underscores how urgently we need more data. Others point out that even temporary side effects, such as blurry vision (especially in older people), need to be closely monitored.
As one retina specialist explained, blood sugar control can change the shape of the lens, which can blur vision, but the worst risk is to the optic nerve.
Experts recommend a baseline eye exam before starting semaglutide, followed by ongoing ophthalmologic monitoring during treatment, particularly for patients with eye risk factors or prior diabetic eye disease.
What Ozempic and Wegovy Maker Can Do
When lawsuits are filed, they do more than seek justice for affected individuals. These cases can force a change that protects potential patients in the future. Common industry-wide outcomes from mass tort lawsuits against defective drug manufacturers include:
Better Labeling: We can demand that their medication guides include a clear, bold warning about the risk of NAION and permanent vision loss.
Stronger Monitoring Protocols: Suits can push for mandatory eye exams and closer follow-up for people starting semaglutide.
Reinforced Accountability: When pharmaceutical companies are held to account, it sends a message: prioritizing profits over people’s health is not acceptable.
Adverse Vision Changes After Ozempic/Wegovy? What to Do Now
1. Seek Medical Evaluation Immediately:
If you have noticed vision changes (even slight blurriness or a haze), reach out to an eye doctor. Mention that you have used semaglutide (Ozempic or Wegovy). Ask about the risk of NAION and whether you should be monitored more closely.
2. Document Everything:
Keep notes of when you started the medication, what dose you used, when vision symptoms began, and all your medical records (eye exams, ophthalmologists’ notes, and any vision-related tests).
3. Talk to a Lawyer Who Understands These Cases:
Our experienced product liability law firm handles a wide range of product liability cases. We know how to review your medical timeline, connect the dots, and hold large companies accountable. Ozempic blindness claims and GLP-1 drugs vision loss claims are being reviewed by our legal team.
You took a medication to improve your life, to manage your diabetes or weight and you followed the instructions. You trusted your healthcare providers and the drug manufacturer. But you were not told about the potential risks and side effects, including severe eye conditions.
How The Yost Legal Group Can Help
When drug manufacturers fail to warn people of serious, permanent risks, they put profit over people. They fail in their responsibility to the very individuals who helped them profit.
At The Yost Legal Group, we refuse to let that stand. We will press for accountability. We will demand transparency. And we will fight to make sure no one else has to face the darkness alone.
If you or someone you know was prescribed Ozempic or Wegovy and then suffered sudden vision loss or blindness, contact The Yost Legal Group. Do not wait. There is no time to delay when your vision is at stake. Call 1-800-967-8529 for a free case consultation with a compassionate defective drug attorney.
Semaglutide Lawsuit – Ozempic Lawyer – Wegovy Lawyer
Wegovy Lawsuit – Blindness From Ozempic – Weight Loss Medications
